
7-Hydroxy-5-methyl-1,3,4-triazaindolizine | CAS:2503-56-2
7-Hydroxy-5-methyl-1,3,4-triazaindolizine
- 名称:7-羟基-5-甲基-1,3,4-三氮杂吲嗪; 7-羟基-5-甲基-1,2,4-三唑并[1,5]嘧啶 | 7-Hydroxy-5-methyl-1,3,4-triazaindolizine
- CAS号:2503-56-2
- 别名:5-Methyl-7-hydroxy-1,2,4-triazolo[1,5-a]pyrimidine; 5-Methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-ol; 5-Methyl-s-triazolo[1,5-a]pyrimidin-7-ol
- 分子式:C6H6N4O
- 分子量:150.14
- EINESC号:219-706-7
产品描述
物理化学性质
熔点 | 280-283 ºC |
---|---|
水溶性 | 不溶 IN COLD WATER |
安全数据
危险品标志 | Xi |
---|---|
危险类别码 | R36/37/38 |
安全说明书 | S26;S36 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
The Journal of Organic Chemistry, 47, 929-929 (1982)
Synthesis of 3-buten-2-one from 4-hydroxy-2-butanone over anatase-TiO2 catalyst.Ichikawa N, et al. Catalysis Communications, 6(1), 19-22 (2005)
Studies on the biosynthesis of cholesterol. 5. Biosynthesis of squalene from DL-3-hydroxy-3-methyl [2-14C] pentano-5-lactone.J W CORNFORTH et al.The Biochemical journal, 69(1), 146-155 (1958-05-01)
Efficient biosynthesis of (R)-3-amino-1-butanol by a novel (R)-selective transaminase from Actinobacteria sp.Xiao-Ling Tang et al.Journal of biotechnology, 295, 49-54 (2019-03-12)
Journal of the American Chemical Society, 79, 2316-2316 (1957)
Cu(I)-catalyzed reductive aldol cyclizations: diastereo- and enantioselective synthesis of beta-hydroxylactones.Hon Wai Lam et al.Organic letters, 7(19), 4225-4228 (2005-09-09)
Journal of the American Chemical Society, 104, 5486-5486 (1982)
Nanotube-supported bioproduction of 4-hydroxy-2-butanone via in situ cofactor regeneration.Liang Wang et al.Applied microbiology and biotechnology, 94(5), 1233-1241 (2011-11-26)
First experimental determination of the absolute gas-phase rate coefficient for the reaction of OH with 4-hydroxy-2-butanone (4H2B) at 294 K by vapor pressure measurements of 4H2B.Gisèle El Dib et al.The journal of physical chemistry. A, 117(1), 117-125 (2012-12-06)
Journal of the American Chemical Society, 67, 400-400 (1945)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!